Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 12/2015

01-12-2015

Safety and long-term outcomes of percutaneous endoscopic gastrostomy in patients with head and neck cancer

Authors: Richard E. Burney, Benjamin S. Bryner

Published in: Surgical Endoscopy | Issue 12/2015

Login to get access

Abstract

Background

Percutaneous endoscopic gastrostomy (PEG) is used for nutritional support during treatment in patients with head and neck cancer, but long-term nutritional outcomes have not been reported in detail. The purpose of this study was to determine short- and long-term outcomes and success in meeting nutritional goals in patients with head and neck cancer who had PEGs placed over an 18-year period.

Methods

Medical records of all patients who had PEG procedures performed by one of the authors (REB) from 1997 through 2010 were reviewed. Demographic data, patient weights, timing of procedure in relation to cancer treatment, complications, and long-term outcomes were recorded.

Results

Five hundred and sixty-five patients with head and neck cancer underwent PEG. Mean age was 59.6 ± 13.6 years; 71 % were men. Mean follow-up was 33 ± 38 months. 99 % of PEGs were used for nutritional support. Average weight loss prior to PEG was 23 ± 17 lbs (range 0–133 lbs). Average weight loss between PEG and completion of treatment was 2.3 lbs; 44 % of patients gained weight or remained stable after PEG. There were no PEG-related deaths. Complications included cellulitis in 27 (4 %), pain in 14 (2.5 %); leakage in 11 (2 %), self-limited gastric bleeding in one patient. PEGs were used an average of 8.1 months. No PEG site tumor implants were observed. Among 366 patients treated with intention to cure, 45 % were alive an average of 68 months later.

Conclusions

PEG is both safe and efficacious in arresting weight loss and maintaining nutrition in patients undergoing surgery and/or chemoradiotherapy for head and neck cancer. PEG can be recommended for patients in whom dysphagia and weight loss is anticipated or in whom weight loss occurs as a result of their treatment; 20 % of patients will need the PEG for a year or more.

Literature
  1. Gauderer MW, Ponsky JL, Izant RJ (1980) Gastrostomy without laparotomy A percutaneous endoscopic technique. J Ped Surg 15(6):872–875View Article
  2. Hunter JG, Lauretano L, Shellito PC (1989) Percutaneous endoscopic gastrostomy in head and neck cancer patients. Ann Surg 210(1):42–46PubMed CentralView ArticlePubMed
  3. Rabeneck L, Wray NP, Petersen NJ (1996) Long-term outcomes of patients receiving percutaneous endoscopic gastrostomy tubes. J Gen Intern Med 11:287–293View ArticlePubMed
  4. Grant DG, Bradley PT, Pothier DD, Bailey D, Caldera S, Baldwin DL, Birchall MA (2009) Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and metaanalysis. Clin Otolaryngol 34:103–112View ArticlePubMed
  5. Ahmed KA, Samant S, Vieira F (2005) Gastrostomy tubes in patients with advanced head and neck cancer. Laryngoscope 115(1):44–47View ArticlePubMed
  6. McLaughlin BT, Gokhale AS, Shuai Y, Diacopoulos J, Carrau R, Heron DE, Smith RP, Gibson MK, Ferris RL, Grandis JR, Johnson JT, Argiris A (2010) Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: the University of Pittsburgh experience. Laryngoscope 120:71–75View ArticlePubMed
  7. Jl Locher, Bonner JA, Carroll WR, Caudell JJ, Keith JN, Kilgore ML, Ritchie CS, Roth DL, Tajeu GS, Allison JJ (2011) Prophylactic percutaneous endoscopic gastrostomy in treatment of head and neck cancer: a comprehensive review and call for evidence based medicine. J Parenter Enteral Nutr 35(3):365–374View Article
  8. Lawson JD, Gaultney J, Saba N, Grist W, Davis L, Johnstone PA (2009) Percutaneous feeding tubes in patents with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation. Am J Otolaryngol 30(4):244–249View ArticlePubMed
  9. Raykher A, Correa L, Russo L, Brown P, Lee N, Pfister D, Gerdes H, Shah J, Kraus D, Schattner M, Shike M (2009) The role of pretreatment percutaneous endoscopic gastrostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient. J Parenter Enteral Nutr 33(4):404–410View Article
  10. Itkin M, DeLegge H, Fang JC, McClave SA, Kundu S, d’Othee BJ, Martinez-Salazar G, Sacks D, Swan T, Tobin R, Walker G, Wojak J, Zuckerman D, Cardella J (2011) Multidisciplinary practical guidelines for gastrointestinal Access for enteral nutrition and decompression. J Vasc Interv Radiol 22:1089–1106View ArticlePubMed
  11. Smith BM, Perring P, Engoren M, Sferra JJ (2008) Hospital and long-term outcome after percutaneous endoscopic gastrostomy. Surg Endosc 22:75–80
  12. Morgenstern L, Laquer M, Treyzon L (2005) Ethical challenges of percutaneous endoscopic gastrostomy. Surg Endosc 19:398–400View ArticlePubMed
  13. Wolf GT, Forastiere A, Ang K, Brockstein B, Conley C, Goepfert H, Kraus D, Lefevre J, Pajak TF, Pfister D, Urba S (1999) Organ preservation strategies in advanced head and neck cancer–current status and future directions. Head Neck 21:689–693View ArticlePubMed
  14. Urba SG, Forastiere AA, Wolf GT, Esclamado RM, McLaughln PW, Thornton AF (1994) Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. J Clin Oncol 12(5):946–953PubMed
  15. Adelson RT, Yadranko D (2005) Metastatic head and neck carcinoma to a percutaneous endoscopic gastrostomy site. Head Neck 27:339–343View ArticlePubMed
Metadata
Title
Safety and long-term outcomes of percutaneous endoscopic gastrostomy in patients with head and neck cancer
Authors
Richard E. Burney
Benjamin S. Bryner
Publication date
01-12-2015
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 12/2015
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-015-4126-9

Other articles of this Issue 12/2015

Surgical Endoscopy 12/2015 Go to the issue

OriginalPaper

Pain during sexual activity before and after laparoscopic inguinal hernia repair

OriginalPaper

Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study

OriginalPaper

Risk factors associated with diagnostic discrepancy of gastric indefinite neoplasia: Who need en bloc resection?

Technique

Comparison of two laparoscopic splenectomy plus pericardial devascularization techniques for management of portal hypertension and hypersplenism

OriginalPaper

Perioperative outcome of unilateral versus bilateral inguinal hernia repairs in TAPP technique: analysis of 15,176 cases from the Herniamed Registry

OriginalPaper

Trans-oral anterior fundoplication: 5-year follow-up of pilot study